Screener
Lexicon Pharmaceuticals LXRX Asset turnover
Asset turnover at other companies
Other financials
Where this comes from
Calculated from Lexicon Pharmaceuticals’s reported figures.
Based on trailing twelve months.
The source filing: Lexicon Pharmaceuticals’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:05 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001062822-26-000117
FAQ
- What is Lexicon Pharmaceuticals's asset turnover?
- Lexicon Pharmaceuticals (LXRX) reported asset turnover of 0.2× in Q2 2026.
- How has Lexicon Pharmaceuticals's asset turnover changed year-over-year?
- Lexicon Pharmaceuticals's asset turnover decreased by 10.6% year-over-year, from 0.2× to 0.2×.
- What is the long-term trend for Lexicon Pharmaceuticals's asset turnover?
- Over 5 years (2020 to 2025), Lexicon Pharmaceuticals's asset turnover has grown at a 21.7% compound annual growth rate (CAGR), from 0.1× to 0.2×.
- What does asset turnover mean?
- Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.
Ask your AI about Lexicon Pharmaceuticals's asset turnover.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude